Protalix Biotherapeutics Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$33,750	$9,122	$17,851	$15,658
Gross Profit	29,623	4,503	9,527	9,788
EBITDA	21,550	-4,271	2,503	1,532
EBIT	21,146	-4,658	2,131	1,172
Net Income	18,317	-5,504	2,355	164
Net Change In Cash	33,750	9,122	17,851	15,658
Free Cash Flow	21,264	3,265	-4,230	-5,664
Cash	41,712	14,680	13,647	17,895
Basic Shares	83,048	78,546	80,814	81,271

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$52,744	$53,399	$65,494	$47,638
Gross Profit	25,236	29,080	42,512	28,046
EBITDA	-4,035	6,520	12,937	-10,782
EBIT	-5,500	5,216	11,746	-11,868
Net Income	-6,604	2,932	8,312	-14,927
Net Change In Cash	52,744	53,399	65,494	47,638
Free Cash Flow	-13,631	7,392	-2,467	-25,628
Cash	14,680	19,760	23,634	17,111
Basic Shares	78,546	81,057	82,424	48,472